These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12712939)

  • 1. Clinton team lowers drug price 7-fold in Caribbean.
    James JS
    AIDS Treat News; 2003 Mar; (389):7-8. PubMed ID: 12712939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinton Foundation negotiates $140/Year HIV treatment, but U.S. won't buy.
    James JS
    AIDS Treat News; 2004 Mar; (399):2-4. PubMed ID: 15199865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAP. Group presses for price concessions on AIDS drugs.
    AIDS Policy Law; 2003 Jun; 18(12):5. PubMed ID: 12846185
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinton-brokered AIDS drug-price agreement to benefit millions.
    AIDS Policy Law; 2004 Apr; 19(8):1, 4. PubMed ID: 15146825
    [No Abstract]   [Full Text] [Related]  

  • 5. [HIV therapy: tenofir DF is available in 68 developing countries at production costs price].
    Med Klin (Munich); 2003 Jul; 98(7):XV-XVI. PubMed ID: 12945544
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost imposes barrier to HIV treatment in Missouri.
    AIDS Policy Law; 2005 Jul; 20(13):2. PubMed ID: 16044518
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.
    Cohen J
    Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654
    [No Abstract]   [Full Text] [Related]  

  • 8. AIDS: mixed news for patients: medications made more accessible in Africa and the Caribbean than in U.S.
    Sofer D
    Am J Nurs; 2004 Aug; 104(8):20. PubMed ID: 15300025
    [No Abstract]   [Full Text] [Related]  

  • 9. US disburses first round of AIDS funds.
    Surendran A
    Nat Med; 2004 Apr; 10(4):323. PubMed ID: 15156586
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug prices.
    Vázquez E
    Posit Aware; 2003; 14(1):61-2. PubMed ID: 12630376
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV services threatened by cutbacks and drug costs.
    Tighe A
    Nurs Stand; 2008 Jan 9-15; 22(18):33. PubMed ID: 18240803
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug pricing.
    AIDS Treat News; 2001 Jan; (377):6. PubMed ID: 11862811
    [No Abstract]   [Full Text] [Related]  

  • 13. AIDS research. Drug trials without the drugs?
    Cohen J
    Science; 2003 May; 300(5623):1212-3. PubMed ID: 12764159
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug firms drop drug case against South Africa.
    AIDS Policy Law; 2001 May; 16(9):3. PubMed ID: 11668825
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment. HIV drug spending up; Merck offers discounts.
    AIDS Policy Law; 2010 Jun; 25(7):1. PubMed ID: 20607912
    [No Abstract]   [Full Text] [Related]  

  • 16. Merck, Bristol-Myers Squibb announce major price reductions for poorest countries: major access progress but questions remain.
    James JS
    AIDS Treat News; 2001 Feb; (361):5-7. PubMed ID: 12765151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost of access to HIV treatment.
    Galatowitsch P; Siegfried N
    Science; 2006 Dec; 314(5805):1540-1; author reply 1540-1. PubMed ID: 17158305
    [No Abstract]   [Full Text] [Related]  

  • 18. AIDS activists decry steady hikes in HIV drug prices.
    AIDS Policy Law; 2005 Jul; 20(14):1, 4. PubMed ID: 16110523
    [No Abstract]   [Full Text] [Related]  

  • 19. Sustaining treatment costs: who will pay?
    Zewdie D; De Cock K; Piot P
    AIDS; 2007 Jul; 21 Suppl 4():S1-4. PubMed ID: 17620744
    [No Abstract]   [Full Text] [Related]  

  • 20. Glaxo drops drug prices, AIDS foundation drops suit.
    AIDS Policy Law; 2003 May; 18(10):6. PubMed ID: 12809097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.